Nantahala Capital Management
New Canaan, Connecticutnantahalapartners.com
Overview
Nantahala Capital Management is a hedge fund manager that utilizes a long-term fundamental value investing methodology with a primary focus on small to mid-sized U.S. companies, investing in equity, fixed-income, and equity-derivative securities.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Obsidian Therapeutics | Apr 2026 | Private Equity | Co-investor |
| Senti Biosciences | Dec 2024 | PIPE | Co-investor |
| Kiora Pharmaceuticals | Feb 2024 | Private Placement | Co-investor |
| Keystone Dental Group | Sep 2021 | VC Round | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
